VA
Vivani Medical, Inc.
VANI · NASDAQ
$1.24 +2.48% (+$0.03)
1M -10.14%
Market Cap $106.9M
P/E Ratio -
Div. Yield -
ROE 191.05%
Bulios Fair Price
$0.81
34.7% downside
Current Price
$1.24
Undervalued Fair Value Overvalued
According to Bulios Fair Price, VANI is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
30 /100
Expensive P/B 5.64x
P/E N/A
EV/FFO N/A
Growth
0 /100
Declining Book val. growth 29.19%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 73.94%
Asset turnover 0.00x
ROE 191.05%
Debt
69 /100
Low Debt/Equity 0.94x
Current ratio 3.25x
Int. coverage N/A
Stability
1 /100
Unstable Beta 3.28x
Profitable years 0
EPS volatility 116.33%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about VANI
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Adam Mendelsohn
Employees
42
Headquarters
Alameda
Upcoming events
12 NOV
Earnings
Upcoming earnings report